Clinical Trials Logo

Postmenopausal Female Patients clinical trials

View clinical trials related to Postmenopausal Female Patients.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02035813 Completed - Clinical trials for HER2-negative Circulating Tumor Cells

DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).

Start date: January 2014
Phase: Phase 2
Study type: Interventional

Several studies have indicated that determining prevalence and number of circulating tumor cells (CTCs) at various time points during treatment may be an effective tool for assessing treatment efficacy in metastatic breast cancer (MBC). However, even if the prognostic value of CTCs in MBC is well understood, the role of both CTC prevalence and CTC phenotype in predicting treatment response needs further investigation. DETECT IV is a prospective, multicenter, open-label, phase II study in patients with HER2-negative metastatic breast cancer and persisting HER2-negative circulating tumor cells (CTCs). Additional research on CTC dynamics and characteristics will provide a better understanding of the prognostic and predictive value of CTCs and is one step into a more personalized therapy for MBC.